Baseline Therapeutics
PrivateCompany Overview
Baseline Therapeutics is a biotechnology company developing GLP-1 receptor agonist therapeutics for the treatment of addiction disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Baseline Therapeutics Comparables
Compare Baseline Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tempero Bio | 81% | |
| Clearmind Medicine Inc. | 76% | |
| Adial Pharmaceuticals, Inc. | 75% |
Baseline Therapeutics Funding Rounds
Historical fundraising activity
Baseline Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Baseline Therapeutics's valuation, stock price, and market status.
Is Baseline Therapeutics a public or private company?
Baseline Therapeutics is a private company.
What is the current stock price of Baseline Therapeutics?
Baseline Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Baseline Therapeutics worth (valuation)?
Valuation information for Baseline Therapeutics is not publicly available.
Can I buy Baseline Therapeutics stock?
Baseline Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Baseline Therapeutics's last funding round?
Funding round information for Baseline Therapeutics is not publicly available.
Who are the main investors in Baseline Therapeutics?
Investor information for Baseline Therapeutics is not publicly disclosed.
Will Baseline Therapeutics IPO soon?
No public IPO plans have been announced for Baseline Therapeutics.
How can I track Baseline Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Baseline Therapeutics's secondary market activity and sign up for updates.